A Thought on Possible Pathogenesis of Ebola Viral Hemorrhagic Disease and Potential Treatments: Could it Be Thrombotic Thrombocytopenic Purpura-Like Syndrome?

Therapeutic Apheresis and Dialysis

Volumn 20, Issue 1, 2016, Pages 93-98

  Chang, Jae C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; FRESH FROZEN PLASMA;

ARTICLE; BLOOD ANALYSIS; BLOOD CELL COUNT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; HEMODIALYSIS; HUMAN; MOLECULAR PATHOLOGY; OUTCOME ASSESSMENT; PLASMAPHERESIS; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA; BLOOD; BLOOD EXAMINATION; DISEASE MANAGEMENT; HEMORRHAGIC FEVER, EBOLA; PATHOLOGY; PATHOPHYSIOLOGY; PLASMA; PLASMA EXCHANGE; PROCEDURES; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; HEMATOLOGIC TESTS; HEMORRHAGIC FEVER, EBOLA; HUMANS; PLASMA; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RENAL DIALYSIS;

EID: 84958678661     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/1744-9987.12350     Document Type: Article

References (24)

1. Fowler RA, Fletcher T, Fischer, II WA et al. Caring for critically ill patients with Ebola viral disease: perspectives from West Africa. Am J Respir Crit Care Med 2014;190:733-7.
2. Sullivan N, Yang ZY, Nabel GJ. Ebola virus pathogenesis: implications for vaccines and therapies. J Virol 2003;77:9733-7.
3. Feldmann H, Volchkov VE, Volchkova VA, Klenk HD. The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis. Arch Virol Suppl 1999;15:159-69.
4. Wahl-Jensen VM, Afanasieva TA, Seebach J, Stroeher U, Feldmann H, Schnittler HJ. Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. J Virol 2005;79:10442-50.
5. Riabchikova EI, Kolesnikova LV, Rassadkin IuN. Microscopic study of species specific features of hemostatic impairment in Ebola virus infected monkeys. Vestn Ross Akad Med Nauk 1998;3:51-5.
6. Kraisin S, Naka I, Patarapotikul J et al. Association of ADAMTS13 polymorphism with cerebral malaria. Malar J 2011;10:366.
7. Larkin D, de Laat B, Jenkins PV et al. Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition. PLoS Pathog 2009;5:e1000349.
8. Tsai HM. Mechanisms of microvascular thrombosis in thrombotic thrombocytopenic purpura. Kidney Int Suppl 2009;(112):S11-4.
9. Chang JC, Aly ES. Acute respiratory distress syndrome as a major clinical manifestation of thrombotic thrombocytopenic purpura. Am J Med Sci 2001;321:124-8.
10. Kathula SK, Koduri J, Mall S, Chang JC. A case report of total abdominal hysterectomy resulting in acute thrombotic thrombocytopenic purpura with pancreatitis and hepatitis: complete resolution with plasma exchange therapy. Ther Apher Dial 2003;7:373-4.
11. Chang JC, Kathula SK. Various clinical manifestations in patients with thrombotic microangiopathy. J Investig Med 2002;50:201-6.
12. Kortepeter, MG, Bausch, DG, Bray, M. Basic Clinical and Laboratory Features of Filoviral Hemorrhagic Fever. J Infect Dis 2011;204(Suppl 3):S810-6.
13. Hukkanen RR, Liggitt HD, Murnane RD, Frevert CW. Systemic inflammatory response syndrome in nonhuman primates culminating in multiple organ failure, acute lung injury, and disseminated intravascular coagulation. Toxicol Pathol 2009;37:799-804.
14. Fisher-Hoch SP, Platt GS, Lloyd G, Simpson DI, Neild GH, Barrett AJ. Haematological and biochemical monitoring of Ebola infection in rhesus monkeys: implications for patient management. Lancet 1983;2:1055-8.
15. Paessler S, Walker DH. Pathogenesis of the viral hemorrhagic fevers. Annu Rev Pathol 2013;8:411-40.
16. Chang JC, Shipstone A, Llenado-Lee MA. Postoperative thrombotic thrombocytopenic purpura following cardiovascular surgeries. Am J Hematol 1996;53:11-17.
17. Chang JC, Newman RS. Redefining the syndromes of thrombotic microangiopathy. Ther Apher Dial 2004;8:73-4.
18. Saltzman DJ, Chang JC, Jimenez JC et al. Postoperative thrombotic thrombocytopenic purpura after open heart operations. Ann Thorac Surg 2010;89:119-23.
19. Jacobson RJ, Jackson DP. Erythrocyte fragmentation in defibrination syndromes. Ann Intern Med 1974;81:207-9.
20. Nguyen TC1, Han YY, Kiss JE et al. Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med 2008;36:2878-87.
21. Qu L, Kiss JE, Dargo G, Carcillo JA. Outcomes of previously healthy pediatric patients with fulminant sepsis-induced multisystem organ failure receiving therapeutic plasma exchange. J Clin Apher 2011;26:208-13.
22. http://www.cdc.gov/vhf/ebola/hcp/guidance-dialysis.html
23. Mupapa K, Massamba M, Kibadi K et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J Infect Dis 1999;179(Suppl 1):S18-23.
24. Plaimauer B, Kremer Hovinga JA, Juno C et al. Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies. J Thromb Haemost 2011;9:936-44.